Exact quote. In his first press conference as president-elect, Donald Trump insisted that with its high drug prices, Pharma was “getting away with murder.” Others evidently agree, even without the hyperbole. California’s Governor Jerry Brown showed his disdain by signing legislation forcing drug manufacturers to “justify” their need for price increases. Really? Just like oil […]
I thought the FDA was going to be championing a new generation of life-saving medications – not a flood of generics, Dr. Gottlieb.
Do you remember the fanfare accompanying the passage of the 21st Century Cures act in December 2016? For that matter, do you remember when Congress actually passed legislation?
As you’ll recall, the FDA was […]
Do you recall what President Trump tweeted immediately after Merck’s Kenneth Frazier resigned from his American Manufacturing Council? “Now …will have more time to LOWER RIPOFF DRUG PRICES!”
I’m not talking politics. I’m just pointing out that President Trump, like most of the country, evidently believes that pharma is getting rich by charging exorbitant prices for […]
Imagine! Amazon gobbles up Whole Foods! Tesla aims to put a man on Mars! Uber’s looking into flying taxis! Who would have believed it? Actually, the most remarkable aspect of these statements is that they’re already yesterday’s news. That’s how fast advances in technology are changing traditional business models.
Meanwhile, we in healthcare languish in the […]
Where and how they get information about new drugs.
A few will lie and say they get their facts from medical journals (and in published studies of course, not from those silly misleading ads!) Most will say they learned about them from colleagues. If they’re honest, some might even credit pharma reps.
Here’s what nearly all refuse […]
First, we can get behind our industry’s “Share the Savings” initiative, launched in early April, 2017. If you’re unfamiliar with the program, here’s some background.
If you or someone in your family has had a medical procedure recently, you’ve likely been astounded at the huge gap between listed charges and the discounts given to the payer. […]
Three–well–two cheers for Janet Woodcock! Last September, as head of the FDA drug evaluation and research center, Dr. Woodcock pushed through an accelerated approval of eteplirsen (Exondys 51) for Duchenne muscular dystrophy (DMD). For the last 20 years, affected families have lobbied vigorously for at least a “chance to try” this promising drug, which is […]
It was exhilarating, in last December when the Senate joined the House of Representatives to demonstrate that Congress can actually accomplish something. With overwhelming bipartisan support, both bodies passed the 21st Century Cures Act. Donald Trump’s repeated chastisement of the FDA during the campaign for over-regulation and not doing enough to promote cures was also […]
Chess grandmasters, after carefully calculating the implications of their next move, typically pause for one last look at the board – to search for what they cannot see. “What refutation am I overlooking? What hidden disaster awaits me?” In short, they call upon their sense of paranoia.
Great leaders have this skill. They have one eye […]
Remember when a college degree was the key to a rosy future? Well, BA’s aren’t opening as many doors as they used to. Nearly 6% of college grads can’t find a job, and twice as many can’t find a position that fits their talents. What’s worse, many grads are buried in debt – which they […]